Skip to main content
BMJ Open Access logoLink to BMJ Open Access
. 2026 Oct 1;19(10):e270259. doi: 10.1136/bcr-2025-270259

Primary malignant mesothelioma of the tunica vaginalis presenting as hydrocele: imaging pitfalls

Jatin Naidu 1,2,✉, Nikhil G Joseph 3, Mai Mohammed 4, Vasanth Kumar Baskaradoss 5
PMCID: PMC13629637  PMID: 42823143

Summary

A man in his late 70s presented with progressive, painless scrotal swelling. The initial ultrasound was reported as a simple hydrocele, and he was scheduled for surgery. At operation, friable nodules on the tunica vaginalis were biopsied, confirming malignant epithelioid mesothelioma. Staging CT showed no pleural or peritoneal disease, supporting a primary tunica vaginalis origin. As the tunica vaginalis is an embryological continuation of the peritoneum, it is exceptionally rare for mesothelioma to arise here as a true primary rather than as a secondary spread from the peritoneum. This case highlights a rare primary malignant mesothelioma masquerading as a hydrocele, the limitations of ultrasound as a sole diagnostic tool and the importance of maintaining suspicion when operative findings are discordant with imaging.

Keywords: Radiology, Urological cancer

Background

Malignant mesothelioma is a rare but aggressive neoplasm, most often originating in the pleura or peritoneum. Involvement of the tunica vaginalis testis, an embryological continuation of the peritoneum, accounts for fewer than 3% of all mesotheliomas and is described predominantly in isolated case reports and small series.1–3 It tends to affect older men and typically presents as painless scrotal enlargement, usually attributed to a hydrocele.4 5 Diagnosis is usually made following surgical exploration, and prognosis is poor with high rate of recurrence or nodal metastases.6

While asbestos is a well-established risk factor for pleural mesothelioma, its association with tunical disease is inconsistent.7 Other proposed contributors include chronic hydrocele, trauma, long-standing inflammation and polyoma virus SV40, though definitive causal relationships remain unproven.8

Given its rarity and nonspecific presentation, primary tunical mesothelioma carries major diagnostic and clinical implications. Early recognition is critical, as prompt surgical excision may be curative before local or distant spread.2 3 6 9 Awareness among radiologists and urologists can therefore directly influence outcomes.

This case contributes to the limited literature on primary tunica vaginalis mesothelioma and underscores the importance of careful imaging interpretation and early biopsy in atypical cases even if initially appearing benign or risk factors are absent.

Case presentation

A man in his late 70s reported several months of progressive, painless left-sided scrotal swelling. He had no systemic symptoms.

He had worked in a non-industrial office-based job with no known exposure to asbestos or industrial chemicals. There was no history of prior scrotal trauma, chronic hydrocele, radiation, or family history of malignancy. He was a lifelong non-smoker. Examination showed a fluctuant, transilluminable swelling consistent with hydrocele.

Ultrasound was reported as uncomplicated hydrocele and elective hydrocele surgery was arranged. Intraoperatively, multiple red friable nodules were seen on the tunica vaginalis and biopsied (figure 1).

Figure 1. Intraoperative photograph showing multiple red, friable nodules studding the tunica vaginalis, consistent with malignant mesothelioma.

Intraoperative view of an open surgical field reveals numerous nodules studding the tunica vaginalis, with extensive involvement across exposed tissue surfaces.

Investigations

  1. Ultrasound (initial): Reported as hydrocele on the affected side; retrospective review revealed subtle mural nodularity (figure 2)

  2. Histopathology (intraoperative biopsy of tunica vaginalis nodules): The tumour comprised tubulopapillary structures and solid groups of atypical epithelioid cells with irregular hyperchromatic nuclei and nuclear pleomorphism, with focal extension into the epididymis. Moderate nuclear atypia and >5 mitoses per 2 mm² were present (figure 3). Immunohistochemistry showed positivity for AE1/3, calretinin, WT1 and D2-40, with patchy positivity for CK7 and desmin (figure 4); negative for BerEP4, CK5/6, CEA and CK20. Features were consistent with malignant epithelioid mesothelioma. No sarcomatoid component was identified (figure 5).

  3. Ancillary molecular testing: BAP1 immunohistochemistry demonstrated preserved nuclear expression. p16 (CDKN2A) fluorescence in situ hybridisation (FISH) showed loss of expression (homozygous deletion), supporting a diagnosis of malignant mesothelioma.

  4. Serum tumour markers: alpha-fetoprotein (AFP), human chorionic gonadotrophin (β-HCG) and lactate dehydrogenase (LDH) levels obtained post-operatively were normal.

  5. CT of the chest, abdomen and pelvis (contrast-enhanced): No pleural or peritoneal thickening, masses or nodal disease to suggest extratesticular mesothelioma (figure 6).

Figure 2. Scrotal ultrasound of the left hemiscrotum. (A, B) Longitudinal views demonstrating anechoic fluid collection with no mural nodularity (arrows), consistent with a hydrocele. (C) Transverse view with colour Doppler showing no vascularised soft tissue.

Scrotal ultrasound of the left hemiscrotum shows longitudinal views with anechoic fluid and no mural nodularity, indicating hydrocele. Transverse Doppler view confirms absent vascularized soft tissue.

Figure 3. Histological sections of the tunica vaginalis lesion showing epithelioid mesothelioma with tubulopapillary and solid architecture, nuclear atypia, brisk mitotic activity and focal epididymal involvement (H&E stain, original magnifications×20, ×100, ×200).

H&E stained sections show epithelioid mesothelioma with tubulopapillary and solid growth patterns, nuclear atypia and mitotic activity at increasing magnifications.

Figure 4. Immunohistochemical staining showing strong diffuse positivity for mesothelial markers (WT1), supporting the diagnosis of malignant epithelioid mesothelioma (H&E counterstain; magnifications ×10–20).

Immunohistochemistry micrographs show strong diffuse WT1 positivity in tumour cells, contrasting with minimal staining in adjacent tissue, confirming epithelioid mesothelioma at low and high magnification.

Figure 5. Immunohistochemical section showing absence of staining for carcinoma-associated markers (example: BerEP4), confirming mesothelial rather than epithelial phenotype (H&E counterstain; ×4).

Low-magnification immunohistochemical section showing absent BerEP4 staining across a large tissue section with lobular architecture, confirming mesothelial phenotype with visible stromal channels throughout.

Figure 6. Contrast-enhanced CT abdomen (axial slice) demonstrating no pleural, peritoneal or nodal involvement, consistent with disease confined to the tunica vaginalis.

Axial contrast-enhanced CT of the abdomen showing iodine contrast with no peritoneal, pleural or nodal involvement, suggesting disease confined to the tunica vaginalis.

Differential diagnoses

Hydrocele was the working diagnosis. Other considerations included epididymal cyst, spermatocele, haematocele, inguinal hernia, testicular tumour and paratesticular lesions (eg, adenomatoid tumour). Malignant mesothelioma was only suspected intraoperatively.

Treatment

The patient initially underwent elective surgery for presumed hydrocele, during which the fluid was drained and multiple friable nodules were identified on the tunica vaginalis. These nodules were excised intraoperatively and sent for histopathological analysis, confirming malignant epithelioid mesothelioma.

The case was subsequently discussed at a specialist mesothelioma multidisciplinary team (MDT). Given the absence of radiological metastatic disease, complete macroscopic excision of visible lesions, favourable epithelioid histology and the patient’s clinical status, radical inguinal orchiectomy was not pursued. The patient is currently under active surveillance with six monthly contrast-enhanced CT-CAP and scrotal ultrasound.

Discussion

Malignant mesothelioma of the tunica vaginalis testis is rare, representing <3% of all mesotheliomas and only a minute proportion of paratesticular tumours.10 While many cases reflect secondary spread from pleural or peritoneal disease, true primary tumours are exceptional but clinically important because aetiology, prognosis and management differ.9 11 Unlike pleural or peritoneal mesotheliomas, which are strongly associated with asbestos exposure, primary tunical tumours show weak or inconsistent links.10 12 Secondary disease usually requires multimodal therapy, whereas early surgical resection may be sufficient in selected primary cases.2 9

Diagnosis is frequently delayed as the tumour often masquerades as benign hydrocele. Ultrasound remains the first-line investigation for scrotal swelling, but small mural nodules can be missed. In our case, the preoperative scan was reported as a simple hydrocele, with subtle nodularity only appreciated retrospectively. This emphasises the limitations of ultrasound as a sole diagnostic tool and the value of repeat targeted imaging or senior radiologist review when clinical or intraoperative findings are discordant.13–15 A proposed diagnostic algorithm for painless scrotal swelling in older men is presented in figure 7. Adjunct modalities such as Doppler ultrasound and MRI may better delineate vascularised or papillary lesions, but definitive diagnosis rests on histopathology.14–17 Staging CT of the chest, abdomen and pelvis is essential to exclude pleural or peritoneal disease; in our patient, the absence of such involvement confirmed a primary origin.

Figure 7. Stepwise diagnostic algorithm for painless scrotal swelling in older men, highlighting the role of ultrasound, intraoperative biopsy, histopathology and staging CT to identify primary malignant mesothelioma of the tunica vaginalis. Abbreviations: AFP, alpha-fetoprotein; β-hCG, beta-human chorionic gonadotropin; IHC, immunohistochemistry; LDH, lactate dehydrogenase; MDT, multidisciplinary team.

Seven-step flowchart for diagnosing painless scrotal swelling, guiding from clinical assessment and red flags through scrotal ultrasound, surgical exploration, histopathology, staging CT and specialist MDT management.

Morphologically, this was a high-grade epithelioid malignant tumour with an infiltrative growth pattern, pleomorphic nuclei, frequent mitotic figures and areas of necrosis. Based on morphology, benign entities such as reactive mesothelial hyperplasia and adenomatoid tumour were excluded.

The mesothelial origin was confirmed by strong, diffuse positivity for calretinin, WT1 and D2-40. Patchy desmin positivity was also observed. While reactive mesothelial proliferations often exhibit focal desmin expression, malignant mesotheliomas are usually desmin-negative, though occasional focal staining has been reported.18 In this case, the morphology and mesothelial marker profile strongly supported malignant mesothelioma, so the patchy desmin positivity was not given significant diagnostic weight.

CK5/6 staining was negative. Although CK5/6 is typically positive in epithelioid mesotheliomas, rare high-grade tumours may lack expression.16 19 Positivity for calretinin, WT1 and D2-40, together with the morphological features, confirmed the diagnosis despite this atypical finding.

In diagnostically challenging cases, ancillary molecular studies such as BAP1 immunohistochemistry and p16 (CDKN2A) FISH may confirm mesothelial malignancy.20–23 In our case, following Regional Mesothelioma MDT referral, BAP1 showed preserved nuclear expression (retained BAP1 has been described in a subset of mesotheliomas),20 22 while p16 showed loss of expression (homozygous deletion), supporting malignancy.

Malignant mesothelioma is subclassified into epithelioid, sarcomatoid and biphasic subtypes, with prognostic implications extrapolated primarily from pleural disease. Epithelioid mesothelioma, as seen in our patient, carries the most favourable prognosis, with median survival of 13–20 months in pleural disease, compared with 6–8 months for sarcomatoid or biphasic subtypes.24 25 The epithelioid variant is also the most common in tunical disease, accounting for approximately 80% of reported cases.26 Sarcomatoid and biphasic tumours are associated with higher rates of aggressive local recurrence and distant metastasis. Our patient’s pure epithelioid morphology, low-volume disease and negative staging CT may favour a less aggressive course, though evidence specific to tunical disease remains limited.

As a single case report, this study cannot establish causation, identify prognostic factors or demonstrate treatment efficacy. The decision to pursue surveillance rather than radical orchiectomy was based on individual patient factors and MDT consensus; this approach requires validation through larger series. Our findings should be interpreted as hypothesis-generating.

Our case adds to the limited literature by demonstrating a primary tunical mesothelioma with no recognised risk factors and no nodal or distant spread. Epidemiological reviews estimate fewer than 300 cases reported worldwide from 1943 to 2018, most occurring in men in the sixth to eighth decades, with a slight left-sided predominance.10 Asbestos exposure is documented in only about a quarter of reported cases.10 More recent reports continue to underline the diagnostic challenge, with many tumours identified only intraoperatively.27–29

The optimal management remains undefined, with no dedicated NICE or international guidelines. Most published series report radical inguinal orchiectomy as primary treatment, often with adjuvant therapy for high-risk features.2 Recurrence rates following orchiectomy alone are substantial (53%),30 and many relapses are distant, suggesting occult micrometastatic disease may be present even with negative staging.31

In our patient, the mesothelioma MDT elected active surveillance rather than orchiectomy or adjuvant therapy based on (1) complete macroscopic excision with histologically negative margins; (2) negative staging CT; (3) asymptomatic status, normal tumour markers and ECOG 0; (4) patient preference after shared decision-making; and (5) favourable epithelioid subtype. We acknowledge this deviates from the dominant paradigm. Some clinicians would advocate orchiectomy regardless of intraoperative findings, or adjuvant chemotherapy extrapolated from pleural mesothelioma.9 However, evidence for adjuvant therapy in tunical mesothelioma is limited to case reports, and toxicity in an elderly asymptomatic patient may outweigh uncertain benefits.

We recognise that active surveillance risks undertreatment of a biologically aggressive malignancy. Radical inguinal orchiectomy remains the standard of care in most published series; clinicians should not deviate without specialist MDT input and careful patient selection. Our patient is followed with six monthly imaging, and any progression will prompt salvage orchiectomy and/or systemic therapy.

Our case does not establish efficacy of surveillance over orchiectomy but highlights that in carefully selected patients with completely excised, low-volume, epithelioid-only disease and negative staging, surveillance may be a reasonable alternative within a specialist MDT setting. Prospective registry data are urgently needed.

Learning points.

  • Hydrocele can conceal significant tunical pathology; careful ultrasound scrutiny of the tunica vaginalis for mural nodularity is essential.

  • Primary mesothelioma of the tunica vaginalis should be considered in persistent or atypical scrotal swelling, even when risk factors are absent.

  • Intraoperative identification of tunical excrescences warrants biopsy to prevent diagnostic delay.

  • Staging CT of the chest, abdomen and pelvis is required to exclude pleural or peritoneal involvement and guide management.

  • Histopathological morphology remains the cornerstone of diagnosis; atypical marker expression should be interpreted in balance and in the context of morphological assessment and other markers.

Footnotes

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent for publication: Consent obtained directly from patient(s).

References

  • 1.Gilbert A, Wieland R, Zacher N, et al. Metastatic Mesothelioma of the Tunica Vaginalis Presenting as Scrotal and Abdominal Nodules: A Case Report and Review of the Literature. Am J Dermatopathol. 2025;47:e6–11. doi: 10.1097/DAD.0000000000002848. [DOI] [PubMed] [Google Scholar]
  • 2.Stella S, Ceresoli GL, Dallari B, et al. Mesothelioma of the Tunica Vaginalis Testis: Diagnostic and Therapeutic Management. A Comprehensive Review, 1982–2024. Cancers (Basel) 1982;16:3956. doi: 10.3390/cancers16233956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rathinasamy N, Menon S, Prakash G, et al. Multimodal Management of Testicular Mesothelioma - A Retrospective Analysis From a Tertiary Cancer Care Centre. Clin Genitourin Cancer. 2023;21:124–7. doi: 10.1016/j.clgc.2022.09.001. [DOI] [PubMed] [Google Scholar]
  • 4.Shaker N, Blankenship H, Shaker N, et al. Malignant Para-Testicular Mesothelioma: A Rare Presentation in the Tunica Vaginalis of an Elderly Male With No Prior Asbestos Exposure. Int J Surg Pathol. 2024;32:1117–22. doi: 10.1177/10668969231215426. [DOI] [PubMed] [Google Scholar]
  • 5.Dagdeviren ZC, Amac O, Dere Y, et al. Primary Malignant Mesothelioma of the Tunica Vaginalis Presenting as a Benign Scrotal Mass: A Case Report. Cureus. 2025;17 doi: 10.7759/cureus.90608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Nazemi A, Nassiri N, Pearce S, et al. Testicular Mesothelioma: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors. Urology. 2019;126:140–4. doi: 10.1016/j.urology.2019.01.009. [DOI] [PubMed] [Google Scholar]
  • 7.Attanoos RL, Gibbs AR. Primary malignant gonadal mesotheliomas and asbestos. Histopathology. 2000;37:150–9. doi: 10.1046/j.1365-2559.2000.00942.x. [DOI] [PubMed] [Google Scholar]
  • 8.Butnor KJ, Pavlisko EN, Sporn TA, et al. Mesothelioma of the tunica vaginalis testis. Hum Pathol. 2019;92:48–58. doi: 10.1016/j.humpath.2019.07.009. [DOI] [PubMed] [Google Scholar]
  • 9.Plas E, Riedl CR, Pflüger H. Malignant mesothelioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters. Cancer. 1998;83:2437–46. doi: 10.1002/(sici)1097-0142(19981215)83:12<2437::aid-cncr6>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  • 10.Vimercati L, Cavone D, Delfino MC, et al. Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (southern Italy) mesothelioma register. Environ Health . 2019;18:1–24. doi: 10.1186/s12940-019-0512-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vijayan S, Carr R, Strachan J. Primary and Secondary Mesothelioma of the Tunica Vaginalis: a comparative case study. BJUI. 2012;110:42–5. doi: 10.1002/BJUIw-2011-127-web. [DOI] [Google Scholar]
  • 12.Addison J, Davies LST. Analysis of amphibole asbestos in chrysotile and other minerals. Ann Occup Hyg. 1990;34:159–75. doi: 10.1093/annhyg/34.2.159. [DOI] [PubMed] [Google Scholar]
  • 13.Drevinskaite M, Patasius A, Kevlicius L, et al. Malignant mesothelioma of the tunica vaginalis testis: A rare case and review of literature. BMC Cancer. 2020;20:1–6. doi: 10.1186/s12885-020-6648-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bertolotto M, Boulay-Coletta I, Butini R, et al. Imaging of mesothelioma of tunica vaginalis testis. Eur Radiol. 2016;26:631–8. doi: 10.1007/s00330-015-3887-9. [DOI] [PubMed] [Google Scholar]
  • 15.Boyum J, Wasserman NF. Malignant mesothelioma of the tunica vaginalis testis: a case illustrating Doppler color flow imaging and its potential for preoperative diagnosis. J Ultrasound Med. 2008;27:1249–55. doi: 10.7863/jum.2008.27.8.1249. [DOI] [PubMed] [Google Scholar]
  • 16.Chekol SS, Sun CC. Malignant Mesothelioma of the Tunica Vaginalis Testis: Diagnostic Studies and Differential Diagnosis. Arch Pathol Lab Med. 2012;136:113–7. doi: 10.5858/arpa.2010-0550-RS. [DOI] [PubMed] [Google Scholar]
  • 17.Fujisaki M, Tokuda Y, Sato S, et al. Case of mesothelioma of the tunica vaginalis testis with characteristic findings on ultrasonography and magnetic resonance imaging. Int J Urol . 2000;7:427–30. doi: 10.1046/j.1442-2042.2000.00225.x. [DOI] [PubMed] [Google Scholar]
  • 18.Attanoos RL, Griffin A, Gibbs AR. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology. 2003;43:231–8. doi: 10.1046/j.1365-2559.2003.01686.x. [DOI] [PubMed] [Google Scholar]
  • 19.Sharma S, Yadav R, Bansal P, et al. Malignant Mesothelioma of Tunica Vaginalis of Testis: Revisiting A Rare Entity. JOJUN . 2024;8:555745. doi: 10.19080/JOJUN.2024.08.5559745. [DOI] [Google Scholar]
  • 20.Husain AN, Chapel DB, Attanoos R, et al. Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2024;148:1251–71. doi: 10.5858/arpa.2023-0304-RA. [DOI] [PubMed] [Google Scholar]
  • 21.Şeker NS, Tekin E, Ak G, et al. Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma. Diagn Cytopathol. 2024;52:211–6. doi: 10.1002/dc.25272. [DOI] [PubMed] [Google Scholar]
  • 22.Hwang HC, Pyott S, Rodriguez S, et al. BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas. Am J Surg Pathol. 2016;40:714–8. doi: 10.1097/PAS.0000000000000616. [DOI] [PubMed] [Google Scholar]
  • 23.Chevrier M, Monaco SE, Jerome JA, et al. Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology. Cancer Cytopathol. 2020;128:939–47. doi: 10.1002/cncy.22326. [DOI] [PubMed] [Google Scholar]
  • 24.Farzin M, Toon CW, Clarkson A, et al. Loss of expression of BAP1 predicts longer survival in mesothelioma. Pathology. 2015;47:302–7. doi: 10.1097/PAT.0000000000000250. [DOI] [PubMed] [Google Scholar]
  • 25.Mansur A, Potter AL, Zurovec AJ, et al. An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma. Chest. 2023;163:1292–303. doi: 10.1016/j.chest.2022.12.019. [DOI] [PubMed] [Google Scholar]
  • 26.Winstanley AM, Landon G, Berney D, et al. The immunohistochemical profile of malignant mesotheliomas of the tunica vaginalis: a study of 20 cases. Am J Surg Pathol. 2006;30:1–6. doi: 10.1097/01.pas.0000178094.07513.71. [DOI] [PubMed] [Google Scholar]
  • 27.Reed SJ, Nasui S, Farber N. Atypical presentation of testicular mesothelioma. Afr J Urol. 2023;29:1–3. doi: 10.1186/s12301-023-00402-1. [DOI] [Google Scholar]
  • 28.Punatar CB, Jadhav KK, Kumar V, et al. Malignant mesothelioma of tunica vaginalis without any risk factors: An uncommon case. J Cancer Res Ther. 2019;15:S167–9. doi: 10.4103/jcrt.JCRT_1403_16. [DOI] [PubMed] [Google Scholar]
  • 29.Nazar T, Gopalakrishnabhaktan A, Tashrifwala FAA, et al. Testicular mesothelioma disguised as hydrocele: a case report. J Med Case Rep. 2024;18:114. doi: 10.1186/s13256-024-04348-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Akin Y, Bassorgun I, Basara I, et al. Malignant mesothelioma of tunica vaginalis: an extremely rare case presenting without risk factors. Singapore Med J. 2015;56:e53–5. doi: 10.11622/smedj.2015053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Brun C, Giusiano S, Thiam K, et al. The necessity of a more aggressive initial surgical treatment in patients with mesothelioma of the testicular tunica vaginalis. Ann Med Surg (Lond) 2019;47:57–60. doi: 10.1016/j.amsu.2019.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES